Vijay Modur

Vijay Modur, M.D., Ph.D., is a highly accomplished physician-scientist who was recently appointed as Chief Medical Officer at BPGbio Inc., a leading AI-powered biopharma company focusing on oncology, neurology, and rare diseases.1

Professional Background

Dr. Modur brings over 25 years of experience as a drug developer to his new role at BPGbio.1 His career has been marked by significant contributions to the advancement of translational medicine and the development of novel therapeutics and diagnostics for various rare diseases.

Education and Certifications

• Doctor of Philosophy (Ph.D.) from the University of Utah School of Medicine
• Bachelor of Medicine (MBBS) from Karnataka University, Dharwad, India
• Residency training in Pathology and Laboratory Medicine at Washington University in St. Louis
• Board Certified in Clinical Pathology by the American Board of Pathology2

Previous Positions

Throughout his career, Dr. Modur has held several leadership positions in the pharmaceutical and biotech industries:

• Head of Research and Development at Eloxx Pharmaceuticals
• Chief Scientific and Medical Officer at Zikani Therapeutics
• Global Project Head - Rare Disease Clinical Development at Sanofi Genzyme
• Translational Medicine Lead at Sanofi Genzyme
• Director, Clinical Research Physician at Novartis Oncology
• Associate Director at Merck1

Expertise

Dr. Modur is known for his expertise in:

• Rare disease clinical development
• Translational medicine
• Biomarker discovery
• Diagnostic development
• Clinical research
• Drug pipeline advancement2

In his new role at BPGbio, Dr. Modur will continue to advance clinical trials and join the company's Leadership Team. His appointment comes as BPGbio plans for late-stage trials in oncology and rare diseases.1